Abstract | OBJECTIVE: METHODS: A central pathologic review and a search of the medical records from 14 collaborating institutions from 1986 to 2017 identified 4708 women with a malignant ovarian neoplasm. Data for young women with Stage I BOT were extracted. To compare recurrence-free survival between the surgery groups, Cox regression analyses and the IPTW-adjusted Kaplan-Meier method were employed. RESULTS: During a median follow-up of 62.0 (1.2-270.4) months, 10 of the 285 patients identified (3.5%) developed recurrence. In multivariate analysis, the practice of cystectomy was not a significant prognostic indicator of recurrence-free survival (hazard ratio [95% confidence interval] 1.276 [0.150-10.864]; P = 0.823). In the IPTW-adjusted cohort, the 5-year recurrence-free survival rates were 95.8% and 96.0% in patients receiving cystectomy and salpingo-oophorectomy, respectively (P = 0.378). CONCLUSION: If patients are selected appropriately, cystectomy in itself may not increase tumor recurrence in young women with early-stage BOT. A large-scale prospective clinical study is necessary to validate this finding.
|
Authors | Yoshiki Ikeda, Masato Yoshihara, Nobuhisa Yoshikawa, Satoshi Tamauchi, Akira Yokoi, Kimihiro Nishino, Kaoru Niimi, Hiroaki Kajiyama |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 157
Issue 2
Pg. 437-443
(May 2022)
ISSN: 1879-3479 [Electronic] United States |
PMID | 34324200
(Publication Type: Journal Article, Multicenter Study)
|
Copyright | © 2021 International Federation of Gynecology and Obstetrics. |
Topics |
- Cystectomy
- Female
- Humans
- Neoplasm Recurrence, Local
(pathology)
- Neoplasm Staging
- Ovarian Neoplasms
(pathology)
- Ovariectomy
(methods)
- Prospective Studies
- Retrospective Studies
|